Gossamer Bio Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 18c
August 8, 2019 5:22 PM EDTGossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.74), $0.18 worse than the analyst estimate of ($0.56).
Over the last several months, we have made significant progress advancing our diversified development portfolio, with five clinical trials now active, said Sheila Gujrathi, M.D., Co-Founder and... More
